The National Institutes of Health (NIH) is offering the HIV Vaccine Research and Design (HIVRAD) Program grant to support projects focusing on AIDS prophylactic vaccine discovery research. This grant allows for multi-component, multi-disciplinary research projects with a specific emphasis on extensive modeling of vaccine concepts in non-human primates. The closing date for applications is March 13, 2020, 12:00:00 AM EDT.
Opportunity ID: 297927
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-319 |
| Funding Opportunity Title: | HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 13, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Mar 13, 2020 |
| Current Closing Date for Applications: | Mar 13, 2020 |
| Archive Date: | Apr 18, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $2,500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) State governments Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts Special district governments County governments For profit organizations other than small businesses City or township governments Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to support multi-component, multi-disciplinary projects that address scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive modeling of vaccine concepts in non-human primates may be included. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-319.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00235370 | Oct 25, 2017 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00258970 | Feb 13, 2018 | Mar 13, 2020 | View |
Package 1
Mandatory forms
297927 RR_SF424_2_0-2.0.pdf
297927 PHS398_CoverPageSupplement_4_0-4.0.pdf
297927 RR_OtherProjectInfo_1_4-1.4.pdf
297927 PerformanceSite_2_0-2.0.pdf
297927 RR_KeyPersonExpanded_2_0-2.0.pdf
297927 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
297927 PHS_Additional_IndirectCosts-1.0.pdf
297927 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
297927 RR_SF424_2_0-2.0.pdf
297927 PHS398_CoverPageSupplement_5_0-5.0.pdf
297927 RR_OtherProjectInfo_1_4-1.4.pdf
297927 PerformanceSite_2_0-2.0.pdf
297927 RR_KeyPersonExpanded_2_0-2.0.pdf
297927 PHS398_ResearchPlan_4_0-4.0.pdf
297927 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
297927 PHS_Additional_IndirectCosts-1.0.pdf
297927 PHS_AssignmentRequestForm_3_0-3.0.pdf